Royalty Report: Medical, Device, Supply – Collection: 27325


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 7


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 7

Primary Industries

  • Medical
  • Device
  • Supply
  • Dental
  • Chemicals
  • Coating

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27325

License Grant
The Company has an exclusively license, on a worldwide basis from a Belgian company, certain intellectual property including patents primarily related to two dental products for human implantation.
License Property
Bioactive Glass Granules and Titanium Fibre Reinforced Bioactive Glass Dental Implant shall mean the biomedical materials.
Field of Use
The rights granted relate to two dental products for human implantation.

IPSCIO Record ID: 29324

License Grant
The Licensee entered into a licensing Agreement with the Canadian Licensor whereby the Licensee acquired a worldwide exclusive License to the technology relating to the Ti-Foam Dental Implant System.  The Agreement extends to 2021, for the duration of patents covering the technology.  The licensor, subject to re-imbursement of 100% of such costs, is required to obtain and maintain the patents covering the technology.
License Property
The proprietary Ti-FOAMâ„¢ technology is a porous titanium dental implant system with significant performance and cost advantages over existing technologies – a 3rd generation Ti implant technology.

IPSCIO Record ID: 89713

License Grant
The Company assumed an exclusive world-wide, royalty bearing license, as well as the right to sublicense, for the use of certain developed technologies related to spine repair with an undisclosed Licensee.
License Property
Bioactive glass is a group of synthetic silicate-based materials, characterized by their bioactivity and their unique bone-bonding properties. Bioactive glass is composed mainly of silica, sodium oxide, calcium oxide and phosphates. The bone-bonding reaction results from a sequence of reactions in the glass and its surface.
Field of Use
This agreement pertains to the medical industry related to spine repair for the treatment of patients suffering from a broad array of musculoskeletal conditions.

IPSCIO Record ID: 28746

License Grant
Pursuant to a License Agreement entered into with the Hospital, the Company is obligated to make royalty payments for the grant of a license for a certain laser technology applied to dental products manufactured by the Company.
Field of Use
The Field of Use apply to the dental industry.

IPSCIO Record ID: 27872

License Grant
The Company entered into a licensing agreement with Licensor, subsidiary, for the manufacture and sale of certain dental products
License Property
Proprietary high-technology dental products

IPSCIO Record ID: 226071

License Grant
The Company assumed an exclusive license agreement with an undisclosed Licensee for bioactive bone graft putty.
License Property
Bioactive bone graft putty is an FDA cleared bioactive synthetic bone graft substitute comprised of a mixture of calcium phosphate granules and bioglass granules suspended in a resorbable polymer carrier that facilitates handling and delivery of the granule components to fill spaces of missing bone. The product is indicated as a bone void filler for standalone use in posterolateral spine fusion procedures without the aid of autologous extenders or enhancers to meet the needs of the surgeon and effectively facilitate structural fusion of the spine. The ratio of certain components in Signafuse’s composition is similar to ratios found to promote attachment and bone formation to produce a stable scaffold that allows sustained bioactivity and osteoconductivity during the healing process. The patented bioactive component is designed for a faster rate of bone fill than bioglass particles with a broader size range. In vitro studies have demonstrated the product’s effective phosphate layer formation on the surface of the implant as early as seven days after application.

IPSCIO Record ID: 27324

License Grant
The Company and the University entered into a license agreement granting the Company an exclusive, worldwide right and license to use and sell products that utilize technology protected by the University of Pennsylvania’s patent rights for use in medical, dental and veterinary fields for growth of bone cells, fixing human prosthetic devices, coating human prosthetic devices, including bone growth onto or into modified human prosthetic device and/or producing human prosthetic devices.
License Property
The University owns and is a proprietor of certain intellectual property developed relating to novel materials and techniques for improving orthopedic implants.
Field of Use
Field of Use means the use of Penn Technical Information and/or Penn Patent Rights  for use in medical, dental and veterinary fields for growth of bone cells, fixing human prosthetic devices, coating human prosthetic devices, inducing bone growth onto or into modified human prosthetic devices, and/or producing human prosthetic devices.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.